Literature DB >> 25652226

Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.

Christine L Chan1, Laura Pyle2, Megan Kelsey1, Lindsey Newnes1, Philip S Zeitler1, Kristen J Nadeau1.   

Abstract

Hemoglobin A1c (HbA1c) is increasingly performed over the oral glucose tolerance test (OGTT) as the initial screening test for type 2 diabetes in youth. However, the optimal strategy for identifying type 2 diabetes in youth remains controversial. Alternate glycemic markers have been proposed as potentially useful tools for diabetes screening. We examined the relationships among fructosamine (FA), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG) with traditional screening tests, HbA1c and OGTT. Youth 10-18 yrs, BMI ≥85th‰, and HbA1c <7.5% had a single visit with measurement of HbA1c, 1,5-AG, FA, GA, and a standard OGTT. Distributions of FA, GA, and 1,5-AG by HbA1c and 2-hour glucose (2hG) categories were compared. Receiver operating characteristic (ROC)-curves were generated to determine the cut points at which alternate markers maximized sensitivity and specificity for predicting prediabetes and diabetes. One hundred and seventeen, 62% female, 59% Hispanic, 22% White, 17% black, median 14.1 yr, and body mass index (BMI) z-score 2.3 participated. Median values of each alternate marker differed significantly between prediabetes and diabetes HbA1c and 2hG categories (p < 0.017). Only GA medians differed (p = 0.006) between normal and prediabetes HbA1c. Area under the receiver operating characteristic curves (ROC-AUCs) for alternate markers as predictors of prediabetes (0.5-0.66) were low; however, alternate marker ROC-AUCs for identifying diabetes (0.82-0.98) were excellent. Although the alternate markers were poor predictors of prediabetes, they all performed well predicting diabetes by 2hG and HbA1c. Whereas the usefulness of these markers for identifying prediabetes is limited, they may be useful in certain scenarios as second line screening tools for diabetes in overweight/obese youth.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  1,5-anhydroglucitol; 2-hour post-OGTT glucose; fasting plasma glucose; fructosamine; glycated albumin; hemoglobin A1c; oral glucose tolerance testing; prediabetes; type 2 diabetes

Mesh:

Substances:

Year:  2015        PMID: 25652226     DOI: 10.1111/pedi.12258

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  13 in total

1.  A1C Combined With Glycated Albumin Improves Detection of Prediabetes in Africans: The Africans in America Study.

Authors:  Anne E Sumner; Michelle T Duong; Paola C Aldana; Madia Ricks; Marshall K Tulloch-Reid; Jay N Lozier; Stephanie T Chung; David B Sacks
Journal:  Diabetes Care       Date:  2015-12-17       Impact factor: 19.112

2.  Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.

Authors:  Christine L Chan; Laura Pyle; Megan M Kelsey; Lindsey Newnes; Amy Baumgartner; Philip S Zeitler; Kristen J Nadeau
Journal:  Pediatr Diabetes       Date:  2016-11-22       Impact factor: 4.866

Review 3.  Pediatric Clinical Endpoint and Pharmacodynamic Biomarkers: Limitations and Opportunities.

Authors:  Jean C Dinh; Chelsea M Hosey-Cojocari; Bridgette L Jones
Journal:  Paediatr Drugs       Date:  2020-02       Impact factor: 3.022

4.  Hemoglobin A1c Accurately Predicts Continuous Glucose Monitoring-Derived Average Glucose in Youth and Young Adults With Cystic Fibrosis.

Authors:  Christine L Chan; Emma Hope; Jessica Thurston; Timothy Vigers; Laura Pyle; Philip S Zeitler; Kristen J Nadeau
Journal:  Diabetes Care       Date:  2018-04-19       Impact factor: 19.112

5.  Development of Diagnostic Fragment Ion Library for Glycated Peptides of Human Serum Albumin: Targeted Quantification in Prediabetic, Diabetic, and Microalbuminuria Plasma by Parallel Reaction Monitoring, SWATH, and MSE.

Authors:  Arvind M Korwar; Garikapati Vannuruswamy; Mashanipalya G Jagadeeshaprasad; Ramesha H Jayaramaiah; Shweta Bhat; Bhaskaran S Regin; Sureshkumar Ramaswamy; Ashok P Giri; Viswanathan Mohan; Muthuswamy Balasubramanyam; Mahesh J Kulkarni
Journal:  Mol Cell Proteomics       Date:  2015-05-28       Impact factor: 5.911

6.  The performance of glycated albumin as a biomarker of hyperglycemia and cardiometabolic risk in children and adolescents in the United States.

Authors:  Amelia S Wallace; Mary R Rooney; Tammy M Brady; Justin B Echouffo-Tcheugui; Robert Christenson; Morgan E Grams; Elizabeth Selvin
Journal:  Pediatr Diabetes       Date:  2021-12-26       Impact factor: 4.866

Review 7.  Identifying Prediabetes and Type 2 Diabetes in Asymptomatic Youth: Should HbA1c Be Used as a Diagnostic Approach?

Authors:  Mary Ellen Vajravelu; Joyce M Lee
Journal:  Curr Diab Rep       Date:  2018-06-04       Impact factor: 4.810

8.  Potential Markers of Dietary Glycemic Exposures for Sustained Dietary Interventions in Populations without Diabetes.

Authors:  Edith Feskens; Lorraine Brennan; Pierre Dussort; Matthieu Flourakis; Lena M E Lindner; David Mela; Naila Rabbani; Wolfgang Rathmann; Frédérique Respondek; Coen Stehouwer; Stephan Theis; Paul Thornalley; Sophie Vinoy
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

9.  A1C Underperforms as a Diagnostic Test in Africans Even in the Absence of Nutritional Deficiencies, Anemia and Hemoglobinopathies: Insight From the Africans in America Study.

Authors:  Sara M Briker; Jessica Y Aduwo; Regine Mugeni; Margrethe F Horlyck-Romanovsky; Christopher W DuBose; Lilian S Mabundo; Thomas Hormenu; Stephanie T Chung; Joon Ha; Arthur Sherman; Anne E Sumner
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-07       Impact factor: 5.555

Review 10.  Novel biomarkers for prediabetes, diabetes, and associated complications.

Authors:  Brenda Dorcely; Karin Katz; Ram Jagannathan; Stephanie S Chiang; Babajide Oluwadare; Ira J Goldberg; Michael Bergman
Journal:  Diabetes Metab Syndr Obes       Date:  2017-08-14       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.